Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1954 2
1955 1
1956 2
1957 5
1958 8
1959 9
1960 7
1961 4
1962 13
1963 6
1964 13
1965 2
1966 5
1967 18
1968 3
1969 10
1970 7
1971 11
1972 12
1973 12
1974 8
1975 13
1976 11
1977 10
1978 8
1979 8
1980 7
1981 7
1982 8
1983 10
1984 8
1985 18
1986 22
1987 18
1988 24
1989 24
1990 18
1991 12
1992 15
1993 18
1994 15
1995 16
1996 15
1997 18
1998 12
1999 9
2000 4
2001 6
2002 5
2003 3
2004 3
2005 8
2006 11
2007 14
2008 10
2009 9
2010 16
2011 14
2012 11
2013 9
2014 15
2015 16
2016 8
2017 8
2018 8
2019 6
2020 7
2021 16
2022 23
2023 22
2024 16
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

760 results

Results by year

Filters applied: . Clear all
Page 1
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation.
Kumar A, Soumerai J, Abramson JS, Barnes JA, Caron P, Chhabra S, Chabowska M, Dogan A, Falchi L, Grieve C, Haydu JE, Johnson PC, Joseph A, Kelly HE, Labarre A, Lue JK, Martignetti R, Mi J, Moskowitz A, Owens C, Plummer S, Puccio M, Salles G, Seshan V, Simkins E, Slupe N, Zhang H, Zelenetz AD. Kumar A, et al. Among authors: johnson pc. Blood. 2025 Jan 30;145(5):497-507. doi: 10.1182/blood.2024025563. Blood. 2025. PMID: 39437708 Free PMC article. Clinical Trial.
Space medicine.
Johnson PC Jr. Johnson PC Jr. Am Sci. 1984 Sep-Oct;72(5):495-7. Am Sci. 1984. PMID: 11540794 Review.
Community-acquired fungal pneumonias.
Johnson PC, Sarosi GA. Johnson PC, et al. Semin Respir Infect. 1989 Mar;4(1):56-63. Semin Respir Infect. 1989. PMID: 2652235 Review.
Hemodynamics.
Johnson PC. Johnson PC. Annu Rev Physiol. 1969;31:331-52. doi: 10.1146/annurev.ph.31.030169.001555. Annu Rev Physiol. 1969. PMID: 4885773 Review. No abstract available.
Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trial.
Soumerai JD, Mato AR, Dogan A, Seshan VE, Joffe E, Flaherty K, Carter J, Hochberg E, Barnes JA, Hamilton AM, Abramson JS, Batlevi CL, Matasar MJ, Noy A, Owens CN, Palomba ML, Kumar A, Takvorian T, Ni A, Choma M, Friedman C, Chadha P, Simkins E, Ruiters J, Sechio S, Portman D, Ramos L, Nolet N, Mahajan N, Martignetti R, Mi J, Scorsune K, Lynch J, McGree B, Hughes S, Grieve C, Roeker LE, Thompson M, Johnson PC, Roshal M, Huang J, Biondo J, Wu Q, Jacob A, Abdel-Wahab O, Zelenetz AD. Soumerai JD, et al. Among authors: johnson pc. Lancet Haematol. 2021 Dec;8(12):e879-e890. doi: 10.1016/S2352-3026(21)00307-0. Lancet Haematol. 2021. PMID: 34826411 Free PMC article. Clinical Trial.
The endocrine system in space flight.
Leach CS, Johnson PC, Cintrón NM. Leach CS, et al. Among authors: johnson pc. Acta Astronaut. 1988;17(2):161-6. doi: 10.1016/0094-5765(88)90017-3. Acta Astronaut. 1988. PMID: 11537094 Review.
Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis.
Kaulen LD, Karschnia P, Doubrovinskaia S, Abramson JS, Martinez-Lage M, Shankar G, Choi BD, Barnes JA, El-Jawahri A, Hochberg EP, Johnson PC, Soumerai JD, Wick W, Maus MV, Chen YB, Frigault MJ, Dietrich J. Kaulen LD, et al. Among authors: johnson pc. Am J Hematol. 2024 Dec;99(12):2411-2415. doi: 10.1002/ajh.27505. Epub 2024 Oct 23. Am J Hematol. 2024. PMID: 39440883
Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphoma.
Frigault MJ, Yao N, Berger TR, Wehrli M, Gallagher KME, Horick N, Graham CE, Jacobson CA, Chen YB, Leick MB, DeFilipp Z, El-Jawahri AR, Johnson PC, Dolaher M, Katsis K, Kim AI, Crombie J, Merryman RW, Cook D, Trailor M, Cho H, Jeffrey R 3rd, Shen R, Filosto S, Nater J, Getz G, Haradhvala NJ, Maus MV. Frigault MJ, et al. Among authors: johnson pc. Blood Adv. 2025 May 13;9(9):2122-2135. doi: 10.1182/bloodadvances.2024015161. Blood Adv. 2025. PMID: 39928957 Free PMC article. Clinical Trial.
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes.
Assatova B, Willim R, Trevisani C, Haskett G, Kariya KM, Chopra K, Park SR, Tolstorukov MY, McCabe SM, Duffy J, Louissaint A Jr, Huuhtanen J, Bhattacharya D, Mustjoki S, Koh MJ, Powers F, Morgan EA, Yang L, Pinckney B, Cotton MJ, Crabbe A, Ziemba JB, Brain I, Heavican-Foral TB, Iqbal J, Nemec R, Rider AB, Ford JG, Koh MJ, Scanlan N, Feith DJ, Loughran TP Jr, Kim WS, Choi J, Roels J, Boehme L, Putteman T, Taghon T, Barnes JA, Johnson PC, Jacobsen ED, Greenberg SA, Weinstock DM, Jain S. Assatova B, et al. Among authors: johnson pc. Clin Cancer Res. 2024 Jun 3;30(11):2514-2530. doi: 10.1158/1078-0432.CCR-23-3504. Clin Cancer Res. 2024. PMID: 38252421 Free PMC article.
760 results